Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Huakang Biomedical Holdings Co Ltd

8622
Current price
0.2 HKD +0.008 HKD (+4.10%)
Last closed 0.19 HKD
ISIN KYG4644W1069
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Hong Kong Stock Exchange
Capitalization 86 590 110 HKD
Yield for 12 month +79.65 %
1Y
3Y
5Y
10Y
15Y
8622
21.11.2021 - 28.11.2021

Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, development, manufacture, marketing, and sale of in-vitro diagnostic (IVD) reagents in the People's Republic of China, Hong Kong, and Canada. The company provides male fertility IVD, parasite antibody detection, and Epstein-Barr virus antibody detection reagents; and auxiliary reproductive supplies and equipment. It also offers healthcare products and supplements under the Nutronic brand through its websites, including nutronic.ca and nutronic.hk; offline channels, such as Eugenebaby and green price shops; and e-commerce platforms comprising Tmall, JD.com, Amazon, HKTVmall, Eugenebaby, etc. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is based in Tsim Sha Tsui, Hong Kong. Address: Kimberley House, Tsim Sha Tsui, Hong Kong

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

+26 972 779 HKD

Last Year

+27 740 488 HKD

Current Quarter

+7 507 343 HKD

Last Quarter

+6 909 387 HKD

Current Year

+17 624 463 HKD

Last Year

+18 523 590 HKD

Current Quarter

+4 842 811 HKD

Last Quarter

+4 519 740 HKD

Key Figures 8622

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -5 217 511 HKD
Operating Margin TTM -18.69 %
PE Ratio
Return On Assets TTM -6.37 %
PEG Ratio
Return On Equity TTM -10.98 %
Wall Street Target Price
Revenue TTM 25 084 449 HKD
Book Value 0.11 HKD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 4.5 %
Dividend Yield
Gross Profit TTM 16 457 607 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY -41.4 %
Profit Margin -24.34 %

Dividend Analytics 8622

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 8622

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 8622

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.8841
Price Sales TTM 3.4519
Enterprise Value EBITDA -26.9017
Price Book MRQ 1.4034

Financials 8622

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 8622

For 52 weeks

0.08 HKD 0.25 HKD
50 Day MA 0.19 HKD
Shares Short Prior Month
200 Day MA 0.14 HKD
Short Ratio
Shares Short
Short Percent